Physician

Arvind Nishtala, M.D.

According to 2025 Medicare claims, Arvind Nishtala, M.D. (NPI: 1255726949) practices cardiology in the San Rafael, CA market, with the plurality of this provider's patient population coming from Marin, CA. This provider's primary affiliated billing organization is REGENTS UNIV OF CALIFORNIA UCSF (NPI: 1124439807; TIN: 943281662) and primary practice location at 94954-3507.

Nishtala's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,951 traditional Medicare patients, billed 5,861 HCPCS/CPT codes, and received $357,303 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,870 prescription claims across 773 beneficiaries totaling $1,213,979 in drug costs, led by Vyndamax (Tafamidis). Open Payments data shows 19 records totaling $14,204. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,328 to $1,213,979. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$179K$357K2021 Medicare payment: $56,334 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $224,093 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $267,377 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $357,303 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021367773$56,334
20221,2092,856$224,093
20231,5683,435$267,377
20241,9515,861$357,303

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$607K$1.2M2019 Drug cost: $2,328 (USD; Tot_Drug_Cst)2020 Drug cost: $4,505 (USD; Tot_Drug_Cst)2021 Drug cost: $31,174 (USD; Tot_Drug_Cst)2022 Drug cost: $264,092 (USD; Tot_Drug_Cst)2023 Drug cost: $615,078 (USD; Tot_Drug_Cst)2024 Drug cost: $1,213,979 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20191751$2,328
20202350$4,505
202175170$31,174
20222501,135$264,092
20236232,791$615,078
20247733,870$1,213,979

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more6401,201$100
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes209379$97
93306Ultrasound of heart with color-depicted blood flow, rate, direction and valve function792812$53
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's7161,477$13
93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report261282$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VyndamaxTafamidis13390$336,946
EliquisApixaban25817,321$333,256
Repatha SureclickEvolocumab846,380$123,520
XareltoRivaroxaban675,430$99,441
JardianceEmpagliflozin554,350$81,217

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.18$5,404SANOFI-AVENTIS U.S. LLC
Research PaymentsReported research-related payment or transfer-of-value amount.1$8,800Caption Health, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Arvind Nishtala, M.D.?

Tedicare shows public-source Medicare data for Arvind Nishtala, M.D. (NPI 1255726949), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Arvind Nishtala, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Arvind Nishtala, M.D.?

Arvind Nishtala, M.D. is linked to REGENTS UNIV OF CALIFORNIA UCSF (billing NPI 1124439807) in the available physician profile data.

Does Arvind Nishtala, M.D. have Open Payments data?

Arvind Nishtala, M.D. has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.